In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Patterns of Seizure Outcome and Recurrence After Laser Insterstitial Thermal Therapy

    Final Number:
    115

    Authors:
    Victor Du MD; Ashesh Mehta MD, PhD

    Study Design:
    Other

    Subject Category:
    Epilepsy

    Meeting: 2016 ASSFN Biennial Meeting

    Introduction: Laser interstitial thermal therapy (LITT) is gaining acceptance as an alternative to craniotomy for resection of seizure foci. However, long term data and patterns of seizure recurrence are unavailable. We describe outcome on 28 patients undergoing laser ablation for epilepsy, including 23 patients with greater than 1 year outcome.

    Methods: Retrospective chart review was performed for 28 consecutive patients with at least 3 months of followup. When documentation was unavailable, patients were contacted by telephone. Engel and ILAE Outcomes were assessed at 3, 6 month, 1 and 2 year time points.

    Results: One patient was lost to followup. 6 patients had hypothalamic hamartomas (HH) and 22 had medial temporal lobe epilepsy (MTLE). While 94% of patients were seizure-free after 3 months, 15% of these patients had recurrence in the next three months. Of 79% of patients who were seizure free after the first 6 months, 13% of those patients developed seizures in the next 6 months. Only 1/13 (8%) of patients who were seizure free after the first year had seizure recurrence in the second year. At 1 year, 70% of patients in the entire series were seizure-free and the remainder had rare seizures. At 2 years, 54% were still seizure-free, with 30% having rare seizures and the remaining 8% with worse outcome. Best Engel 1 outcomes were seen in MTS (72% at 1 year; 60% two years) and hypothalamic hamartoma and mesial temporal tumors (100% at one and two years)

    Conclusions: LITT demonstrates similar outcomes to those described using traditional open surgery for the treatment of epilepsy at 1 year and beyond for a variety of etiologies. Similarities between techniques apply not only to seizure-free outcome, but success rates with respect to pathology (with MTS and single lesions giving the best results) as well as patterns of recurrence.

    Patient Care: We aim to provide evidence for LITT as a safe and efficacious treatment intervention for focal epilepsies with compelling medium-term seizure outcome results.

    Learning Objectives: To recognize LITT as a safe and efficacious treatment intervention for focal epilepsies such as mesial temporal sclerosis and hypothalamic hamartoma.

    References: Willie JT, Laxpati NG, Drane DL. Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery. 2014;74:15. Tovar-Spinoza Z, Carter, D, Ferrone, D et al. The use of MRI-guided laser-induced thermal ablation for epilepsy. Childs Nerv Syst. 2013;29:5. Wilfong A, Curry, DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia. 2013;54:5. Drees C, Chapman K, Prenger E et al. Seizure outcome and complications following hypothalamic hamartoma treatment in adults: endoscopic, open, and Gamma Knife procedures. J Neurosurg. 2012;117(2):6. Curry D, Gowda A, McNichols RJ, Wilfong AA. MR-guided stereotactic laser ablation of epileptogenic foci in children. Epilepsy Behav. 2012;24:6.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy